Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by GRAMPS1996on Dec 06, 2016 12:53pm

176 Views

Post# 25560814

The Silence

maybe Big Pharma sniffin around ?

Opportunity
Complete a FDA Phase 1/2a human bladder cancer clinical study with FDA breakthrough status
Execution of a strategic partnering agreement with big pharma for destruction of bladder cancer (i.e.: upfront payments , co-development funds, annual recurring revenue streams)

2016 - Milestone 5: Execute strategic partnering agreement with big pharma

Bullboard Posts

Silvercorp to expand into Ecuador with C$200M Adventus acquisition